NYSE: TRAK

ReposiTrak, Inc.

CIK 0000050471 · SIC 7374 · Computer Processing & Data Preparation

Micro Revenue $23M Assets $57M as of Aug 30, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (SPWH 10-Q) is open in full — no account needed.

8-K Filed Aug 18, 2026 · Period ending Aug 18, 2026

Summary not yet generated.

8-K Filed Jul 8, 2026 · Period ending Jul 1, 2026

Summary not yet generated.

Partner

Trade TRAK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 18, 2026 · Period ending Jun 18, 2026

Summary not yet generated.

8-K Filed Jun 3, 2026 · Period ending Mar 29, 2026

ReposiTrak takes $2.3M payment in 3.2M SPAR Group shares instead of cash

3 material changes detected. Sign up free to read the summary.

8-K Filed May 18, 2026 · Period ending May 14, 2026

ReposiTrak reports Q1 FY2026 earnings via press release and conference call

2 material changes detected. Sign up free to read the summary.

10-Q Filed May 14, 2026 · Period ending Mar 31, 2026

revenue $5.9M, net income $2.0M. ReposiTrak revenue growth slows to 5% YTD; issues unsecured loan to SPAR Marketing

5 material changes detected. Sign up free to read the summary.

8-K Filed Mar 24, 2026 · Period ending Mar 20, 2026

ReposiTrak declares $0.02 quarterly dividend, payable May 15 to March 31 holders

2 material changes detected. Sign up free to read the summary.

8-K Filed Mar 20, 2026 · Period ending Mar 16, 2026

ReposiTrak subsidiary lends up to $4M to SPAR Marketing Force at 8%, receives 1M shares

5 material changes detected. Sign up free to read the summary.

10-Q Filed Feb 17, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Sep 29, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-Q Filed May 15, 2025 · Period ending Mar 31, 2025

Summary not yet generated.

10-K Filed Sep 30, 2024 · Period ending Jun 30, 2024

Summary not yet generated.

Latest financial statements

From 10-Q filed May 14, 2026 (period ending Mar 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Condensed Statements of Operations and Comprehensive Income (Unaudited)

Description Three months ended March 31, 2026 Three months ended March 31, 2025 Nine months ended March 31, 2026 Nine months ended March 31, 2025
Revenue 5,883,198 5,913,732 17,711,476 16,845,782
Operating expense:
Cost of revenue and product support 803,353 911,693 2,511,249 2,773,468
Sales and marketing 1,356,865 1,408,861 4,458,676 4,392,997
General and administrative 1,376,346 1,455,602 4,216,435 4,124,706
Depreciation and amortization 95,414 328,723 563,090 913,646
Total operating expense 3,631,978 4,104,879 11,749,450 12,204,817
Income from operations 2,251,220 1,808,853 5,962,026 4,640,965
Other income (expense):
Interest income 321,109 326,388 1,082,011 1,030,554
Interest expense (9,191) (12,817) (29,930) (35,022)
Realized gain (loss) on short term investments 1,194 - (19,052) -
Unrealized gain (loss) on short term investments (128,697) (6,705) (153,852) (2,438)
Income before income taxes 2,435,635 2,115,719 6,841,203 5,634,059
(Provision) for income taxes: (450,000) (149,931) (1,349,999) (452,036)
Net income 1,985,635 1,965,788 5,491,204 5,182,023
Dividends on preferred stock (34,285) (85,725) (139,653) (289,223)
Net income applicable to common shareholders 1,951,350 1,880,063 5,351,551 4,892,800
Weighted average shares, basic 18,205,000 18,254,000 18,254,000 18,249,000
Weighted average shares, diluted 18,838,000 19,143,000 19,029,000 19,122,000
Basic income per share 0.11 0.10 0.29 0.27
Diluted income per share 0.10 0.10 0.28 0.26
Comprehensive income:
Net income 1,985,635 1,965,788 5,491,204 5,182,023
Other comprehensive gain:
Unrealized gain (loss) on available-for-sale securities (31,328) (3,759) (39,917) 15,110
Total comprehensive income 1,954,307 1,962,029 5,451,287 5,197,133

Consolidated Condensed Balance Sheets (Unaudited)

Description March 31, 2026 June 30, 2025
Assets
Current Assets
Cash 26,409,558 28,568,805
Receivables, net of allowance for doubtful accounts of $264,517 and $242,437 at March 31, 2026 and June 30, 2025, respectively 5,101,465 4,133,026
Contract asset unbilled current portion 454,408 428,585
Prepaid expense and other current assets 1,137,554 555,384
Total Current Assets 33,102,985 33,685,800
Property and equipment, net 362,973 602,172
Other Assets:
Notes receivable 3,000,000 -
Deposits and other assets 22,414 22,414
Prepaid expense less current portion 3,453 6,568
Goodwill 20,883,886 20,883,886
Capitalized software costs, net - 128,207
Total Other Assets 23,909,753 21,041,075
Total Assets 57,375,711 55,329,047
Liabilities and Shareholders’ Equity
Current liabilities
Accounts payable 270,175 282,146
Accrued liabilities 2,507,489 1,841,839
Contract liability deferred revenue 3,754,750 3,175,908
Notes payable and financing leases current 234,523 231,225
Total current liabilities 6,766,937 5,531,118
Long-term liabilities
Notes payable and financing leases less current portion 114,939 278,748
Total liabilities 6,881,876 5,809,866
Commitments and contingencies
Stockholders’ equity:
Preferred Stock; $0.01 par value, 30,000,000 shares authorized;
Series B Preferred, 700,000 shares authorized; 160,865 and 336,098 shares issued and outstanding at March 31, 2026 and June 30, 2025, respectively 1,609 3,361
Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,173,565 and 18,282,805 and issued and outstanding at March 31, 2026 and June 30, 2025, respectively 181,738 182,830
Additional paid-in capital 59,063,066 62,181,156
Accumulated other comprehensive loss (51,173) (11,256)
Accumulated deficit (8,701,405) (12,836,910)
Total stockholders’ equity 50,493,835 49,519,181
Total liabilities and stockholders’ equity 57,375,711 55,329,047

Consolidated Condensed Statements of Cash Flows (Unaudited)

Description Nine months ended March 31, 2026 Nine months ended March 31, 2025
Cash flows from operating activities:
Net income 5,491,204 5,182,023
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 563,090 913,646
Amortization of operating right of use asset - 47,386
Stock compensation expense 327,069 302,251
Bad debt expense 675,000 450,000
(Increase) decrease in:
Accounts receivables (1,669,262) (796,122)
Long-term receivables, prepaids and other assets (762,990) (208,916)
Increase (decrease) in:
Accounts payable (11,971) 21,746
Operating lease liability - (47,372)
Accrued liabilities 669,156 (335,917)
Deferred revenue 578,842 1,234,646
Net cash provided by operating activities 5,860,138 6,763,371
Cash flows from investing activities:
Issuance of note receivable (3,000,000) -
Purchase of property and equipment (11,749) (8,795)
Sale (purchase) of marketable securities (39,917) 15,110
Net cash provided by (used in) investing activities (3,051,666) 6,315
Cash flows from financing activities:
Common Stock buyback/retirement (1,798,537) (100,016)
Redemption of Series B Preferred (1,874,993) (2,249,975)
Proceeds from exercise of warrants - 79,120
Proceeds from employee stock plan 104,519 134,345
Dividends paid (1,238,197) (1,342,235)
Payments on notes payable and capital leases (160,511) (310,466)
Net cash used in financing activities (4,967,719) (3,789,227)
Net increase (decrease) in cash and cash equivalents (2,159,247) 2,980,459
Cash and cash equivalents at beginning of period 28,568,805 25,153,862
Cash and cash equivalents at end of period 26,409,558 28,134,321
Supplemental disclosure of cash flow information:
Cash paid for income taxes 709,420 375,119
Cash paid for interest 12,054 7,769
Cash paid for operating leases - 56,244
Supplemental disclosure of non-cash investing and financing activities:
Common stock to pay accrued liabilities 325,136 259,302
Dividends accrued on preferred stock 139,653 289,223
Right-of-use asset - 654,444

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing